| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/09/2011 | CN101058818B Hydantoinase gene, coded amino acid and application thereof |
| 02/08/2011 | USRE42130 Phagemid vectors |
| 02/08/2011 | US7884269 Barley cultivar champion |
| 02/08/2011 | US7884268 Soybean variety D5247567 |
| 02/08/2011 | US7884267 Soybean variety D5632454 |
| 02/08/2011 | US7884266 Soybean cultivar 6238359 |
| 02/08/2011 | US7884264 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues |
| 02/08/2011 | US7884263 reducing the level of nornicotine and N'-nitrosonornicotine (NNN) in Nicotiana plants; tobacco products |
| 02/08/2011 | US7884262 Modified DMO enzyme and methods of its use |
| 02/08/2011 | US7884261 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
| 02/08/2011 | US7884200 For carrying a target gene specific insert into a cell in order to modulate the expression of a target gene; modified Lentivirus vector; used to down-regulate the expression of a particular target gene within a cell |
| 02/08/2011 | US7884199 HCV NS3-NS4 protease resistance mutants |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884197 oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with Toll-like receptors (TLR9) |
| 02/08/2011 | US7884196 for induction and maintenance of regulator suppressor T cells resulting in suppression of non infectious, and post infectious, inflammatory, allergic, autoimmune, vasculitic, certain degenerative vascular, and graft versus host diseases, |
| 02/08/2011 | US7884194 epidermal growth factor receptors 2 and 3 proteins; antiproliferative; cancer |
| 02/08/2011 | US7884192 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884191 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein |
| 02/08/2011 | US7884188 polypeptide obtained from a haematophagous arthropod that inhibits the classical complement pathway and the alternative complement pathway by inhibiting cleavage of C5 by classical and alternative C5 convertases |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884085 Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| 02/08/2011 | US7884084 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |
| 02/08/2011 | US7884082 Combined therapeutical treatment of hyperproliferative diseases |
| 02/08/2011 | US7884070 for treating Cryptococcus infection in humans, animals, and plants |
| 02/08/2011 | US7884054 Methods for identifying functional antibodies |
| 02/08/2011 | US7884053 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883895 capable of modulating exopolysaccharide production in Sphingomonas; using such nucleic acid sequences to generate bacteria that hyper-produce exopolysaccharide in slime form; produce exopolysaccharide in a form that does not increase the viscosity of a fermentation broth |
| 02/08/2011 | US7883894 Directed protein evolution using inhibitors of DNA repair |
| 02/08/2011 | US7883890 Expression vector comprising nucleotide sequences coding fish transposase for use as gene transfer and mutation generation tool |
| 02/08/2011 | US7883889 Using 5-aza-cytidine or 5-aza-2'-deoxycytidine to hypomethylate cells expressing tumor associated antigens; immunotherapy; genetic vaccines and the diagnosis, prevention and treatment of cancer |
| 02/08/2011 | US7883888 Replication incompetent Adenovirus (AdV) vectors, selectively killing cancer cells |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883877 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 02/08/2011 | US7883871 Compositions and methods for reverse transcriptase-polymerase chain reaction (RT-PCR) |
| 02/08/2011 | US7883870 Nucleotide sequences coding bacterial transcription factor for use in detection and characterization of staphylococcal subspecies |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883867 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
| 02/08/2011 | US7883850 Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof |
| 02/08/2011 | US7883845 using Human immunodeficiency virus-1 group O/M envelope polypeptide fusion as evaluative tool in diagnosing viral infection |
| 02/08/2011 | US7883720 Charge-dynamic polymers and delivery of anionic compounds |
| 02/08/2011 | US7883712 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | CA2571067C Novel plant expression constructs |
| 02/08/2011 | CA2555063C Xylanase gene sequences from the genomic dna of unpurified rumen microorganisms |
| 02/08/2011 | CA2424333C Method of detecting norwalk-like virus (gii) |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2393874C Method for selectively isolating a nucleic acid |
| 02/08/2011 | CA2391433C Catalytic rnas with aminoacylation activity |
| 02/08/2011 | CA2386255C Transformants producing secondary metabolites modified with functional groups, and novel biosynthesis genes |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/08/2011 | CA2350207C T cells specific for target antigens and methods and vaccines based thereon |
| 02/08/2011 | CA2325774C Coniothyrium minitans .beta.-(1,3) exoglucanase gene cbeg1 |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2320419C Compositions comprising viruses and methods for concentrating virus preparations |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/08/2011 | CA2295849C Trichoderma reesei swollenin protein and encoding dna sequence |
| 02/08/2011 | CA2285703C Detection of dna damaging agents |
| 02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 02/08/2011 | CA2260818C High fidelity detection of nucleic acid differences by ligase detection reaction |
| 02/08/2011 | CA2260363C Polynucleotide and its use for modulating a defence response in plants |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/04/2011 | CA2732028A1 Herbicide resistant sunflower plants |
| 02/03/2011 | WO2011014885A1 Thermostable type-a dna polymerase mutants with increased polymerization rate and resistance to inhibitors |
| 02/03/2011 | WO2011014816A1 Wd repeat 79 protein targeted therapy |
| 02/03/2011 | WO2011014794A1 Adenoviral-based vectors |
| 02/03/2011 | WO2011014749A1 Axmi-192 family of pesticidal genes and methods for their use |
| 02/03/2011 | WO2011014740A2 Methods and composition for identifying and validating modulators of cell fate |
| 02/03/2011 | WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | WO2011014504A1 Recombinant influenza virus vectors and uses thereof |
| 02/03/2011 | WO2011014458A1 Polypeptides having phytase activity and polynucleotides encoding same |
| 02/03/2011 | WO2011014457A1 Combination treatments |
| 02/03/2011 | WO2011014278A1 Proteases with modified pre-pro regions |
| 02/03/2011 | WO2011013753A1 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
| 02/03/2011 | WO2011013707A1 Method for producing l-amino acid |
| 02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013698A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
| 02/03/2011 | WO2011013131A1 Polynucleotides and constructs encoding sflt1-14 and method for efficient propagation and expression thereof |
| 02/03/2011 | WO2011013130A2 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 02/03/2011 | WO2011013040A1 Aptamers which inhibit the activity of the human rad51 protein, and biological uses thereof |
| 02/03/2011 | WO2011012999A1 Reverse genetics systems |
| 02/03/2011 | WO2011012844A1 Method of preparing polypeptides for cryo-transmission electron microscopy (cryo-em) and structure determination using dna lattices |
| 02/03/2011 | WO2011012841A1 Plasmid dna extraction process |
| 02/03/2011 | WO2011012831A1 Method for purifying active gla-domain coagulation proteins |
| 02/03/2011 | WO2011012830A1 Method for purifying gla-domain coagulation proteins |
| 02/03/2011 | WO2011012779A1 Mutants of pyrroloquinoline quinine-dependent soluble glucose dehydrogenase |
| 02/03/2011 | WO2011012724A1 Widespread gene delivery to the retina using systemic administration of aav vectors |
| 02/03/2011 | WO2011012716A1 Oligonucleotides inhibiting cellular migration |
| 02/03/2011 | WO2011012713A1 Combination of a chemotherapeutic agent and an inhibitor of the tgf-beta system |